Enterochelin, the iron chelator produced by a number of pathogenic enterobacteria, appears to be an essential metabolite for multiplication within the host, where it transports iron from the host iron-binding proteins to the bacteria. Previous work showed that complexes of enterochelin containing either scandium (Sc3+) or indium (In3+) exerted a bacteriostatic effect on Klebsiella pneumoniae in serum, whilst the Sc3+ complex exerted a significant therapeutic effect on mice infected with K. pneurnoniae. These observations have now been extended to a number of pathogenic serotypes of Escherichia coli including those carrying either the K1 antigen or the ColV plasmid. The Sc3+ and In3+ complexes each exert a bacteriostatic effect on these organisms growing in either whole serum or media containing an iron-binding protein. Evidence is presented that the Sc3+ complex may act as a competitive inhibitor of the Fe3+ complex. In contrast to their effects on K. pneumoniae, sideramines other than enterochelin fail to reverse the bacteriostatic effect of the Sc3+ complex of enterochelin in E. coli, suggesting that the complex produces a more profound derangement of metabolism in this organism. The Sc3+ complex exerts a significant therapeutic effect on E. coli infections in mice although the In3+ complex is less active.
INTRODUCTION
The physiochemical state of iron in body fluids is now considered to be of fundamental importance in host resistance to many bacterial infections (for general reviews of iron and infection see Bullen et al., 1978; and Weinberg, 1978) . Bacteria entering the body become exposed to the iron-binding proteins, lactoferrin on mucosal surfaces and transferrin in the plasma. It has been postulated that in order to multiply in the presence of these iron-binding proteins, with which the ferric ion is very strongly associated (Aasa et al., 1963; Aisen & Liebman, 1972) , the bacteria must possess a specific mechanism for assimilating this proteinbound iron (Bullen et al., 1971) .
Under iron-deficient conditions, a number of enterobacterial pathogens including Escherichia coli (Rogers et al., 1977) , Salmonella typhimurium (Pollack & Neilands, 1970) and ShigelIa sonnei (Perry & San Clemente, 1979) secrete enterochelin, the cyclic trimer of 2,3-dihydroxy-N-benzoyl serine. This compound appears to be a virulence factor for both E. coli (Rogers, 1973) and S. typhimurium (Yancey et a/., 1979) . This idea is supported by the observations that enterochelin can remove Fe3+ from its complex with transferrin (Carrano & Raymond, 1979) and that it can abolish the bacteriostatic effect of serum on E. coli (Rogers et al., 1977) . Since enterochelin appears to be an essential growth factor for this important group of pathogens under the ironrestricted conditions imposed by the host, it was reasoned that complexes of enterochelin with ions other than Fe3+ might act as antimetabolites to ferric enterochelin. Of 19 complexes tested, only those containing either scandium or indium exerted a bacteriostatic effect on Klebsiella pneumoniae.The scandium complex exerted a therapeutic effect similar to that of kanamycin sulphate on K. pneumoniae infections in mice . The present paper describes the antibacterial activity of these complexes on certain pathogenic serotypes of E. coli. A preliminary account of this work has been published (United Kingdom Patent 2022076, 1979) . complex formed a fine suspension which settled out on standing but could be dispersed again by vigorous shaking. Without the additon of glycerol, the Sc3+ complex proved extremely difficult to wet and disperse. These solutions appeared to be stable for at least one week at 4 "C. Solutions of the Fe3+ complex were prepared in the same way as the In3+ complex but appeared to undergo some decomposition within 24 h.
Microbial iron chelators. Enterochelin, terregens factor, rhodotorulic acid and ferrioxamine B were all obtained as previously described by Rogers er al. (1980) . Haematin solution. A freshly prepared solution of 1 mM-haematin hydrochloride in 0.01 M-NaOH was added to heat-inactivated rabbit plasma to give a final concentration of 10 p~ immediately before inoculation with E. coli 0111.
Mice. Female TO mice weighing 23-25 g were used.
R E S U L T S
Antibacterial efects in serum The addition of either the Sc3+ or In3+ complexes of enterochelin (2 p~; 1.4 and 1.6 p.g ml-1 respectively) to normal rabbit serum in which E. coli 0141 had been growing for 2 h inhibited further growth. In the case of the Sc3+ complex, this was followed by a bactericidal effect (Fig.  1) . When heat-inactivated serum or plasma was used as a growth medium, addition of the complexes resulted in bacteriostasis. The Sc3+ complex of enterochelin also exerted a bacteriostatic effect on E. coli 01/K1 growing in foetal calf serum. This experiment may be considered as a very simple model of neonatal septicaemia. The observation by Williams (1979) that a ColVlinked locus may enhance iron acquisition in invasive strains of E. coli prompted the testing of the Sc3+ complex (2 JLM) against one such strain ( E . coli 018/Kl/H7 COW+), growing in normal rabbit serum. The pattern of growth in the control and test samples was almost identical to that of E. coli 01/K1.
Role of the iron-binding protein
It was postulated that the ferric enterochelin uptake system would be induced by exposing the bacteria to the iron-binding proteins of the host. Only then would the bacteria become sensitive to the inhibitory effects of the Sc3+ complex. The data in Fig. 2 suggest that this is the case, since only a combination of iron-binding protein, in this case conalbumin, and the Sc3+ complex of in TSB containing conalbumin (e); in TSB to which the scandium complex of enterochelin was added at 2 h (0); in TSB containing conalbumin to which the scandium complex of enterochelin was added at 2 h (1). 
coli 01 I I in the presence of various enterochelin complexes
Normal horse serum containing 0.4% (v/v) 01 11 antiserum was inoculated with E. coli 01 1 1 to give an initial population of 3.5 x lo2 organisms ml-'. Portions (1.0 ml) were added to 25 ml bottles containing the test sample (final concentration 2 p~) .
The bottles were incubated for 6 h on a rotary shaker at 37 "C under a stream of moist 5 % (v/v) COz in air. enterochelin were capable of inhibiting the growth of E. coli 01 1 1 in TSB supplemented with 10 pM-Fe2+ and 1 pM-Mn2+. Rogers et al. (1980) suggested that some complexes of enterochelin might decompose by exchanging their metal ion with serum transferrin. Since it is known that the bacteriostatic effect of specific antiserum on E. coli 0 1 1 1 can be reversed by enterochelin (Rogers et al., 1977) , this property has been used in an attempt to differentiate between those complexes which are unstable and those which lack intrinsic antibacterial activity. The results presented in Table 1 show that the V 0 2 + , Y3+ and ZP+ complexes are quite active in stimulating bacterial growth.
Stability of enterochelin complexes in serum

Efect of enterochelin on bacteriostasis
Initial experiments showed that low concentrations of enterochelin (0.2 p~) failed to reverse the inhibitory effect of the Sc3+ complex (2 p~) on E. coli0141 in rabbit plasma. Experiments in H . J . ROGERS, V . E. WOODS AND C. SYNGE 0 1 2 3 4 5 6 7 0 1 2 3 4 5 6 7 Time (h) Time ( which the bacteria were grown in the presence of different concentrations of enterochelin before adding the Sc3+ complex (2 p~) showed that bacteriostasis still occurred after a 2 h delay even in the presence of a 10-fold excess of enterochelin (Fig. 3 ). An attempt was made to determine whether the Fe3+ and Sc3+ complexes of enterochelin act on the bacteria in a competitive manner. The inhibitory effect of the Sc3+ complex (at 0.2 or 2 p~) on E. coli 0141 in rabbit plasma was rapidly reversed by the addition, 2 h later, of either 2 p~ or 20 ~L M ferric enterochelin (Fig. 4) .
Eflect of other ferric iron complexes
Microbial iron-transporting compounds, including ferrioxamine B, ferric rhodotorulate, and particularly terregens factor, are all capable of reversing the inhibitory effect of the Sc3+ complex on K . pneumoniae . In the case of E. coli 0141 however, none of these compounds (at 10 p~) proved capable of reversing the bacteriostatic effect of 2 pM-Sc3+ complex. When added to the rabbit plasma at a concentration of 100 p~ at the beginning of the experiment, ferric ammonium citrate was able to prevent the bacteriostatic effect of both the In3+ and Sc3+ complexes of enterochelin (2 p~) added 2 h later. Haematin (10 p~) however, did not prevent these bacteriostatic effects (data not shown).
Mouse protection tests
Mice were infected by the intraperitoneal route with 1 x lo7 E. coli 0141 (approximately 1 LDloo dose). They then received, 1 h later, 0.2 ml of a 67 p~ solution [approximately 0.4 mg (kg body weight)-'] of various enterochelin complexes by the same route. Since mice given a lethal dose of the organism die within a few hours, deaths were recorded at 20 min intervals for the first 8 h after infection. The results in Table 2 show that of the complexes tested, only those of Sc3+ and In3+ were able to delay death.
In a further test of the protective effect of the Sc3+ complex, 40 mice were each infected with 8 x lo6 E. coli 0141, and 20 animals received 0-2 ml of 1 mM [5.8 mg (kg body weight)-'] Sc3+ complex, 1 and 6 h after infection. Of the untreated mice which served as controls, 90% had died by 32 h, whilst of the treated mice, 80% survived without obvious ill-effects and were killed one month later. In a similar test of the In3+ complex in mice receiving 1-2 x lo7 E. coli 0141, the lives of only a few animals were prolonged during the first 6 h of the experiment but there were no survivors from either group at 24 h.
DISCUSSION
These observations provide further support for the idea that complexes of enterochelin with certain ions other than Fe3+ act as antimetabolites to ferric enterochelin and so inhibit bacterial multiplication by interfering with iron assimilation in the iron-restricted conditions imposed by the serum iron-binding protein, transferrin (Bullen et al., 1971) . Thus, the growth of the four pathogenic serotypes of E. coli used in this work was inhibited by the Sc3+ complex of enterochelin (at 2 p~).
Although the In3+ complex is also active in uitro (Fig. l) , its properties have not been examined in great detail since it was less active in the mouse protection test. A bactericidal effect followed the addition of the Sc3+ complex to E. coli 0141 in normal rabbit serum (Fig. 1) . Heatinactivated serum or plasma in which only bacteriostasis occurs were used subsequently in order to avoid complications which might be imposed by this bactericidal effect. It would be of considerable importance, however, if inhibition by the complex were to render the bacteria more susceptible to the natural defences of the host.
Escherichia coli Ol/Kl growing in foetal calf serum was employed as a model of neonatal sepsis and meningitis (Sarff et al., 1975) . The Sc3+ complex caused rapid inhibition of bacterial growth. Recent work by Williams (1979) suggests that certain invasive strains of E. coli carry a ColV plasmid which codes for an enhanced ability to sequester protein-bound Fe3+. This system appears to operate in addition to the enterochelin system of iron transport. It was found, however, that one such ColV+ strain is just as susceptible to inhibition by the Sc3+ complex of enterochelin as serotypes 0141 and 01.
An attempt has been made in this work to clarify some of the conditions required to render these compounds effective antibacterial agents. Thus, apart from the nature of the complexes themselves , it was also postulated that an iron-restricted environment was required. A suitable iron-restricted environment was produced by means of conalbumin, the iron-binding protein from hen eggs. The ferric enterochelin transport system, which is induced by exposing the bacteria to suitable iron chelators (Rogers, 1973) , is susceptible to inhibition by the Sc3+ complex of enterochelin (Fig. 2) . This experiment, together with that carried out in foetal calf serum, also shows that antibody is not involved in the inhibitory process. Previous work showed that complexes of enterochelin containing either Ru3+, V02+ or Cr3+ stimulated bacterial growth in serum, either as a result of hydrolysis of the complex or exchange reactions with transferrin resulting in free enterochelin . Using E. coli 0 1 11 in which enterochelin release is blocked by specific antibody (Fitzgerald & Rogers 1980) , it has been possible to obtain some indication of the stability of the complexes in serum (Table 1) . Thus, the growth in the presence of Y3+ complex is in accord with its chemical instability. Although the V 0 2 + , Ti4+ and ZP+ complexes are moderately stable to decomposition by Fe3+ , they appear to release sufficient enterochelin in serum to support considerable bacterial growth.
The inhibitory effect of Sc3+ enterochelin on bacterial growth can be reversed by relatively high concentrations of the Fe3+ complex in a manner that suggests competition between the complexes. The failure of metal-free enterochelin (20 VM) to reverse the inhibitory effect could then be explained by its inability to remove sufficient iron from transferrin to compete with the Sc3+ complex. This, in turn, suggests that in order to overcome the inhibitory effect of the complex, the organism would have to produce very high levels of enterochelin. In the case of E. coli 0141 growing in serum, the maximum concentration of enterochelin attained was found to be only 0.48 p~ (Rogers, 1973) .
Previous work has shown that a number of microbial iron transporting compounds could reverse the bacteriostatic effect of the Sc3+ complex on K . pneumoniae . In contrast, these compounds failed to reverse the inhibitory effect of the complex on E. coli 0141. This suggests that exposing the organism to the Sc3+ complex may induce biochemical changes beyond an interruption of the iron supply. The In3+ complex appears to exert similar effects. Both ferric ammonium citrate and haematin abolish the bacteriostatic effect of serum on E. coli 0141 (Bullen & Rogers, 1969) . In contrast, only the former proved capable of preventing the bacteriostatic effect of the complexes on the organism. It is probable that the initial exposure of the bacteria to ferric ammonium citrate served to repress the ferric enterochelin system thus making the bacteria insensitive to the complexes.
The results of preliminary mouse protection tests ( Table 2 ) and experiments in vitro show that the antibacterial properties are confined to the In3+ and Sc3+ complexes of enterochelin. Definitive tests have shown that, as in the case of K . pneumoniae (Rogers et ul., 1980) , the In3+ complex has only a slight therapeutic effect on E. coli 0141 infections in mice whilst the Sc3+ complex exerts a significant therapeutic effect.
